Serum triacylglycerol-lowering effect of soybean β-conglycinin in mildly hypertriacylglycerolemic individuals

Autor:	Hiroshige Itakura, Yasunori Matsui, Setsu Ohara, Takashi Yoshino, Ryoya Komatsu, Makoto Tamesada, Masami Saitou, Tadahiro Tsubakio
Rok vydání:	2007
Předmět:	medicine.medical_specialty business.industry Test group Endocrinology Diabetes and Metabolism Blood lipids Lipid metabolism Placebo Placebo group Endocrinology Internal medicine Medicine Ingestion lipids (amino acids peptides and proteins) Soybean protein business β conglycinin
Zdroj:	e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 2:12-16
ISSN:	1751-4991
DOI:	10.1016/j.eclnm.2006.12.001
Popis:	Summary Background and Aims Recent studies have documented that β -conglycinin, a soybean protein, is effective in improving levels of lipids including serum triacylglycerol. However, β -conglycinin has rarely been studied clinically. In the present study, its effects on serum lipids were examined in subjects with mild hypertriacylglycerolemia. Methods Sixty-eight subjects with serum triacylglycerol levels of 1.70–3.39 mM participated in the present placebo-controlled, randomized, double-blind study. The subjects were administered β -conglycinin 2.3 g in 4 test tablets (weighing 6 g in total) daily in the test group and 4 placebo tablets containing no β -conglycinin in the placebo group for 12 weeks. Results Serum triacylglycerol in the test group was significantly reduced at Weeks 4 ( P P Conclusion Daily ingestion of β -conglycinin appeared to lower serum triacylglycerol levels.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::716489b7862e01e156f81a6d0aaec416 https://doi.org/10.1016/j.eclnm.2006.12.001 Zobrazit plný text záznamu Full Text from ScienceDirect